These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

643 related items for PubMed ID: 6291007

  • 1. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G.
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [Abstract] [Full Text] [Related]

  • 2. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 3. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 4. [Diagnostic value of determining chorionic gonadotropin and trophoblastic beta 1-glycoprotein in trophoblastic disease].
    Grinevich IuA, Tatarinov IuS, Iugrinova LG, Olefirenko GA, Dotsenko IuS.
    Vopr Onkol; 1981 Dec; 27(12):19-23. PubMed ID: 6275607
    [Abstract] [Full Text] [Related]

  • 5. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ, Ploch E, Zalucka K, Sikorowa L, Kaminska JA, Gadek A.
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [Abstract] [Full Text] [Related]

  • 6. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N.
    Akush Ginekol (Sofiia); 1989 Feb; 28(2):15-9. PubMed ID: 2548413
    [Abstract] [Full Text] [Related]

  • 7. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
    Soma H, Kikuchi K, Takayama M, Saegusa H, Saito T, Kashiwagi H, Sayama S.
    Arch Gynecol; 1981 Feb; 230(4):321-7. PubMed ID: 6269502
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M, Soma H, Isaka K, Okudera K, Ogawa T, Kikuchi K.
    Gynecol Obstet Invest; 1987 Feb; 23(3):151-6. PubMed ID: 3036671
    [Abstract] [Full Text] [Related]

  • 9. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 10. Placental proteins (SP1, hCG, PP5) and alpha 2-PAG in trophoblastic diseases.
    Than GN, Bohn H, Csaba IF, Szabó DG, Karg NJ, Göcze P.
    Arch Gynecol; 1981 Jun; 231(1):33-9. PubMed ID: 6174083
    [Abstract] [Full Text] [Related]

  • 11. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ, Engvall E, Schlaerth JB, Morrow CP.
    Am J Obstet Gynecol; 1980 Oct 01; 138(3):313-20. PubMed ID: 6251725
    [Abstract] [Full Text] [Related]

  • 12. Pregnancy-specific beta 1 glycoprotein and chorionic gonadotrophin levels following conception.
    Smith DH, Sinosich MJ, Saunders DM.
    J Reprod Med; 1981 Nov 01; 26(11):555-7. PubMed ID: 6978401
    [Abstract] [Full Text] [Related]

  • 13. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN, Salem HT, Chard T, Huang SC, Ouyang PC.
    Br J Obstet Gynaecol; 1982 Jan 01; 89(1):69-72. PubMed ID: 6277363
    [Abstract] [Full Text] [Related]

  • 14. [Diagnosis and treatment of trophoblastic uterine tumors].
    Kozachenko VP, Toloknov BO, Savinova VF, Grigorova TM.
    Vopr Onkol; 1982 Jan 01; 28(5):97-103. PubMed ID: 6283736
    [Abstract] [Full Text] [Related]

  • 15. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases].
    Kitajima T, Mochizuki M, Nishimura R.
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar 01; 43(3):297-303. PubMed ID: 1710641
    [Abstract] [Full Text] [Related]

  • 16. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct 01; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr 01; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.